Autologous Stem Cell Transplantation After Second Line Brentuximab Vedotin in Relapsed or Refractory Hodgkin Lymphoma.

about

Autologous Stem Cell Transplantation After Second Line Brentuximab Vedotin in Relapsed or Refractory Hodgkin Lymphoma.

Item

http://www.wikidata.org/entity/Q47562175

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Autologous Stem Cell Transplan ...... r Refractory Hodgkin Lymphoma.

@en

Autologous Stem Cell Transplan ...... r Refractory Hodgkin Lymphoma.

@nl

type

Item

label

Autologous Stem Cell Transplan ...... r Refractory Hodgkin Lymphoma.

@en

Autologous Stem Cell Transplan ...... r Refractory Hodgkin Lymphoma.

@nl

prefLabel

Autologous Stem Cell Transplan ...... r Refractory Hodgkin Lymphoma.

@en

Autologous Stem Cell Transplan ...... r Refractory Hodgkin Lymphoma.

@nl

P1476

Autologous stem-cell transplan ...... or refractory Hodgkin lymphoma

@en

P2093

A F Herrera

http://www.w3.org/2001/XMLSchema#string

A Nademanee

http://www.w3.org/2001/XMLSchema#string

F Sahebi

http://www.w3.org/2001/XMLSchema#string

J Palmer

http://www.w3.org/2001/XMLSchema#string

L E Budde

http://www.w3.org/2001/XMLSchema#string

L Popplewell

http://www.w3.org/2001/XMLSchema#string

L W Kwak

http://www.w3.org/2001/XMLSchema#string

N Kennedy

http://www.w3.org/2001/XMLSchema#string

N-C Tsai

http://www.w3.org/2001/XMLSchema#string

P Martin

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis

Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease.

Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease.

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.

Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma.

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.

ESHAP is an active regimen for relapsing Hodgkin's disease.

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma.

P304

724-730

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDX791

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matthew Mei

Tanya Siddiqi

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29272364

http://www.w3.org/2001/XMLSchema#string

P932

5889038

http://www.w3.org/2001/XMLSchema#string